RxDoctor Payments Data

David Walker, DO

Family Medicine · Gahanna, OHNPI 1326028770

Payments from drug & device makers

$8,137in general payments, 2019–2025

Across 520 payments — averaging $15.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$930
  • AstraZeneca$664
  • Lilly USA, LLC$511
  • Pfizer$447
  • Amgen$393
  • plus $4K from 50 others

What the payments were for

  • Food & beverage$8,123100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,137 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$48,582
Medicare patients
135
Services billed
1,510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban67$64,779
OzempicSemaglutide38$56,801
JardianceEmpagliflozin40$35,861
XareltoRivaroxaban27$20,370
JanuviaSitagliptin Phosphate12$15,813
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$13,865
Soliqua 100-33Insulin Glargine/Lixisenatide13$11,117
Tresiba Flextouch U-200Insulin Degludec11$10,089
FarxigaDapagliflozin Propanediol12$7,892
NamzaricMemantine Hcl/Donepezil Hcl12$7,444
Breo ElliptaFluticasone/Vilanterol16$7,038
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$6,490
Tresiba Flextouch U-100Insulin Degludec28$4,536
Atorvastatin Calcium236$3,069
Rosuvastatin Calcium141$2,878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$447$64,77967 claims
Novo NordiskOzempic$930$56,80138 claims
Boehringer IngelheimJardiance$379$35,86140 claims
GSKTrelegy Ellipta, Breo Ellipta$336$20,90338 claims
Johnson & JohnsonXarelto$259$20,37027 claims
MerckJanuvia$124$15,81312 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$258$11,11713 claims
AbbVieNamzaric, Synthroid$1,074$8,77925 claims
AstraZenecaFarxiga$664$7,89212 claims
ANI Pharmaceuticals, Inc.Valsartan$18$1,13530 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Gahanna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →